FI5816U1 - Raseeminen tamsulosiinivapaa emäs - Google Patents

Raseeminen tamsulosiinivapaa emäs

Info

Publication number
FI5816U1
FI5816U1 FI20020421U FIU20020421U FI5816U1 FI 5816 U1 FI5816 U1 FI 5816U1 FI 20020421 U FI20020421 U FI 20020421U FI U20020421 U FIU20020421 U FI U20020421U FI 5816 U1 FI5816 U1 FI 5816U1
Authority
FI
Finland
Prior art keywords
free base
tamsulosin free
racemic tamsulosin
racemic
base
Prior art date
Application number
FI20020421U
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Hans Jan Hoorn
Theodorus Hendricus Ant Peters
Jaroslav Pis
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of FIU20020421U0 publication Critical patent/FIU20020421U0/fi
Application granted granted Critical
Publication of FI5816U1 publication Critical patent/FI5816U1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • C07C303/44Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20020421U 2001-10-31 2002-10-23 Raseeminen tamsulosiinivapaa emäs FI5816U1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33081701P 2001-10-31 2001-10-31
US10/208,009 US6835853B2 (en) 2001-10-31 2002-07-31 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith

Publications (2)

Publication Number Publication Date
FIU20020421U0 FIU20020421U0 (fi) 2002-10-23
FI5816U1 true FI5816U1 (fi) 2003-06-06

Family

ID=26902810

Family Applications (2)

Application Number Title Priority Date Filing Date
FI20020421U FI5816U1 (fi) 2001-10-31 2002-10-23 Raseeminen tamsulosiinivapaa emäs
FI20020420U FI5957U1 (fi) 2001-10-31 2002-10-23 Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20020420U FI5957U1 (fi) 2001-10-31 2002-10-23 Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella

Country Status (17)

Country Link
US (2) US6835853B2 (fr)
EP (2) EP1444198A1 (fr)
CN (2) CN100343227C (fr)
AT (2) ATE417822T1 (fr)
AU (2) AU2002330774B9 (fr)
CA (2) CA2464648C (fr)
CH (3) CH697034A5 (fr)
CZ (2) CZ13392U1 (fr)
DE (3) DE60230438D1 (fr)
DK (2) DK200200338U3 (fr)
FI (2) FI5816U1 (fr)
FR (2) FR2832147B1 (fr)
IL (2) IL161449A0 (fr)
IS (2) IS6603A (fr)
NL (2) NL1021671C2 (fr)
NO (1) NO20042256L (fr)
WO (2) WO2003037850A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
USH2154H1 (en) * 2003-10-08 2006-04-04 Farmak, A.S. Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
US8436029B2 (en) * 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
CN100545148C (zh) * 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
WO2006117662A2 (fr) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Formes polymorphes de (r)-(-)-tamsulosine
US20090137844A1 (en) * 2005-06-15 2009-05-28 Fermion Oy Crystallization process
EP2026766A1 (fr) 2006-05-17 2009-02-25 Synthon B.V. Composition en comprimé pour la libération prolongée de la tamsulosine
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
DE102008002409A1 (de) * 2008-06-13 2009-12-17 Evonik Goldschmidt Gmbh Enzymatische Synthese von Sphingolipiden
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2338876A1 (fr) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Le sel adipate de tamsulosine pour une utilisation pharmaceutique
KR101525493B1 (ko) * 2013-01-02 2015-06-03 보령제약 주식회사 고순도 탐술로신 또는 이의 염 제조방법
CN104926699B (zh) * 2015-07-02 2018-09-25 成都丽凯手性技术有限公司 一种高光学纯度盐酸坦索罗辛的制备方法
CN106631918B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 拆分坦索罗辛对映异构体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383998A (de) * 1959-08-05 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3261829A (en) * 1964-08-12 1966-07-19 Searle & Co Spiro(steroidal-6,3'-1-pyrazolines) and process
CA1147342A (fr) 1977-10-12 1983-05-31 Kazuo Imai Procede de preparation de nouveaux derives de la phenylethanolamine
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
ES2098069T3 (es) * 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
CZ13392U1 (cs) 2003-06-24
DK200200338U3 (da) 2003-07-11
CA2464917C (fr) 2009-06-02
DE20216779U1 (de) 2003-09-04
EP1444199A1 (fr) 2004-08-11
CN1578761A (zh) 2005-02-09
DE60230438D1 (de) 2009-01-29
IS6603A (is) 2003-05-02
FIU20020420U0 (fi) 2002-10-23
NL1021678C2 (nl) 2003-05-15
FR2832147A1 (fr) 2003-05-16
DK200200338U1 (da) 2003-01-31
CH697164A5 (de) 2008-05-30
WO2003037850A1 (fr) 2003-05-08
AU2002330774B2 (en) 2009-06-04
DK200200339U3 (da) 2003-06-13
EP1444198A1 (fr) 2004-08-11
US6965051B2 (en) 2005-11-15
US20030109752A1 (en) 2003-06-12
IL161490A0 (en) 2004-09-27
AU2002330776B2 (en) 2009-03-12
WO2003037851A1 (fr) 2003-05-08
FIU20020421U0 (fi) 2002-10-23
IS6602A (is) 2003-05-02
CA2464917A1 (fr) 2003-05-08
FR2832146A1 (fr) 2003-05-16
AT6687U1 (de) 2004-02-25
FR2832147B1 (fr) 2006-06-02
NO20042256L (no) 2004-07-28
DE20216835U1 (de) 2003-09-25
CH696665A5 (de) 2007-09-14
ATE417822T1 (de) 2009-01-15
FR2832146B1 (fr) 2006-05-26
FI5957U1 (fi) 2003-09-30
IL161449A0 (en) 2004-09-27
DK200200339U1 (da) 2003-01-31
CN100343227C (zh) 2007-10-17
US6835853B2 (en) 2004-12-28
US20050096394A1 (en) 2005-05-05
NL1021671C2 (nl) 2003-05-15
CH697034A5 (de) 2008-03-31
AU2002330774B9 (en) 2010-01-07
CA2464648C (fr) 2009-07-14
CA2464648A1 (fr) 2003-05-08
CN1578762A (zh) 2005-02-09
CN100579958C (zh) 2010-01-13
EP1444199B1 (fr) 2008-12-17
CZ13580U1 (cs) 2003-08-18

Similar Documents

Publication Publication Date Title
DE60210315D1 (de) Tamsulosin tabletten
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
FI5816U1 (fi) Raseeminen tamsulosiinivapaa emäs
DE60235536D1 (de) Sulfonamidderivate
NO20034949L (no) Sulfonamider
DE50200230D1 (de) Tripodegelenk
DE60207950T2 (de) Reflektor
DE50200210D1 (de) Tripodegelenk
ITMI20010954A0 (it) Procedimento di iodurazione
DE60100024D1 (de) Keilsockellampe
NO20011078D0 (no) Motorbase
DE60204723D1 (de) Plattenspieler
ATA3182001A (de) Belagsplatte
ATA15932001A (de) Leuchte
SE0103659D0 (sv) Limfri lampsockel
DK1334086T3 (da) Phenoxyphenylalkansulfonater
FIU20010082U0 (fi) Pohjarakenne
UA5524S (uk) Шафа базова уктс-м-д
FR2829369B1 (fr) Support limonadier
FI20011152A (fi) Pöydän jalkarakenne
FI20011585A (fi) Paikantamisjärjestely
ATA3172001A (de) Belagsplatte
UA5501S (uk) Прожектор заливаючого світла
ES1054258Y (es) Base de enchufe
ES1048238Y (es) Lampara